IBDEI0A4 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4337,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,4338,0)
 ;;=V45.02^^23^226^22
 ;;^UTILITY(U,$J,358.3,4338,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4338,1,4,0)
 ;;=4^V45.02
 ;;^UTILITY(U,$J,358.3,4338,1,5,0)
 ;;=5^S/P Defibrillator Placement
 ;;^UTILITY(U,$J,358.3,4338,2)
 ;;=^303420
 ;;^UTILITY(U,$J,358.3,4339,0)
 ;;=453.9^^23^226^29
 ;;^UTILITY(U,$J,358.3,4339,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4339,1,4,0)
 ;;=4^453.9
 ;;^UTILITY(U,$J,358.3,4339,1,5,0)
 ;;=5^Venous Thrombosis NOS
 ;;^UTILITY(U,$J,358.3,4339,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,4340,0)
 ;;=414.9^^23^226^8
 ;;^UTILITY(U,$J,358.3,4340,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4340,1,4,0)
 ;;=4^414.9
 ;;^UTILITY(U,$J,358.3,4340,1,5,0)
 ;;=5^CHR ISCHEMIC HRT DIS NOS
 ;;^UTILITY(U,$J,358.3,4340,2)
 ;;=^24401
 ;;^UTILITY(U,$J,358.3,4341,0)
 ;;=349.9^^23^226^9
 ;;^UTILITY(U,$J,358.3,4341,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4341,1,4,0)
 ;;=4^349.9
 ;;^UTILITY(U,$J,358.3,4341,1,5,0)
 ;;=5^CNS DISORDER NOS
 ;;^UTILITY(U,$J,358.3,4341,2)
 ;;=^123890
 ;;^UTILITY(U,$J,358.3,4342,0)
 ;;=412.^^23^226^17
 ;;^UTILITY(U,$J,358.3,4342,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4342,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,4342,1,5,0)
 ;;=5^OLD MYOCARDIAL INFARCT
 ;;^UTILITY(U,$J,358.3,4342,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,4343,0)
 ;;=427.89^^23^226^20
 ;;^UTILITY(U,$J,358.3,4343,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4343,1,4,0)
 ;;=4^427.89
 ;;^UTILITY(U,$J,358.3,4343,1,5,0)
 ;;=5^Rhythm Disorder
 ;;^UTILITY(U,$J,358.3,4343,2)
 ;;=^87896
 ;;^UTILITY(U,$J,358.3,4344,0)
 ;;=785.0^^23^226^26
 ;;^UTILITY(U,$J,358.3,4344,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4344,1,4,0)
 ;;=4^785.0
 ;;^UTILITY(U,$J,358.3,4344,1,5,0)
 ;;=5^Tachycardia NOS
 ;;^UTILITY(U,$J,358.3,4344,2)
 ;;=^117041
 ;;^UTILITY(U,$J,358.3,4345,0)
 ;;=277.6^^23^227^1
 ;;^UTILITY(U,$J,358.3,4345,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4345,1,4,0)
 ;;=4^277.6
 ;;^UTILITY(U,$J,358.3,4345,1,5,0)
 ;;=5^Alpha-1 antitrypsin deficiency
 ;;^UTILITY(U,$J,358.3,4345,2)
 ;;=^87463
 ;;^UTILITY(U,$J,358.3,4346,0)
 ;;=494.0^^23^227^5
 ;;^UTILITY(U,$J,358.3,4346,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4346,1,4,0)
 ;;=4^494.0
 ;;^UTILITY(U,$J,358.3,4346,1,5,0)
 ;;=5^Bronchiectasis, chronic
 ;;^UTILITY(U,$J,358.3,4346,2)
 ;;=^321990
 ;;^UTILITY(U,$J,358.3,4347,0)
 ;;=496.^^23^227^7
 ;;^UTILITY(U,$J,358.3,4347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4347,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,4347,1,5,0)
 ;;=5^COPD, General
 ;;^UTILITY(U,$J,358.3,4347,2)
 ;;=COPD, General^24355
 ;;^UTILITY(U,$J,358.3,4348,0)
 ;;=786.2^^23^227^8
 ;;^UTILITY(U,$J,358.3,4348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4348,1,4,0)
 ;;=4^786.2
 ;;^UTILITY(U,$J,358.3,4348,1,5,0)
 ;;=5^Cough
 ;;^UTILITY(U,$J,358.3,4348,2)
 ;;=Cough^28905
 ;;^UTILITY(U,$J,358.3,4349,0)
 ;;=786.09^^23^227^9
 ;;^UTILITY(U,$J,358.3,4349,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4349,1,4,0)
 ;;=4^786.09
 ;;^UTILITY(U,$J,358.3,4349,1,5,0)
 ;;=5^Dyspnea
 ;;^UTILITY(U,$J,358.3,4349,2)
 ;;=Dyspnea^87547
 ;;^UTILITY(U,$J,358.3,4350,0)
 ;;=492.8^^23^227^10
 ;;^UTILITY(U,$J,358.3,4350,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4350,1,4,0)
 ;;=4^492.8
 ;;^UTILITY(U,$J,358.3,4350,1,5,0)
 ;;=5^Emphysema
 ;;^UTILITY(U,$J,358.3,4350,2)
 ;;=Emphysema^87569
 ;;^UTILITY(U,$J,358.3,4351,0)
 ;;=515.^^23^227^14
 ;;^UTILITY(U,$J,358.3,4351,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4351,1,4,0)
 ;;=4^515.
 ;;^UTILITY(U,$J,358.3,4351,1,5,0)
 ;;=5^Interstitial Lung disease
 ;;^UTILITY(U,$J,358.3,4351,2)
 ;;=^101072
 ;;
 ;;$END ROU IBDEI0A4
